Practical, hands-on education about menstruation can help adolescents feel more confident and prepared for the physical and emotional changes associated with their first periods, according to research ...
AAP 2025 heads to Denver with 10,000+ attendees, a keynote by Dr. Glaucomflecken, and 260+ sessions tackling top issues in pediatric care. The American Academy of Pediatrics (AAP) officially kicked ...
The FDA has authorized Essilor Stellest eyeglass lenses to correct myopia and slow progression in children, offering a lower-risk option than contacts. The FDA has authorized the marketing of Essilor ...
Northwestern University has developed a tool for standardized assessment of language, cognitive, motor, and social-emotional skill development in infants aged 16 days to 42 months, publishing the ...
New CDC data show fewer kindergartners are fully vaccinated as exemption rates increased during the 2024-2025 school year. Vaccination coverage among kindergartners in the United States declined ...
U.S. public schools enhance student mental health support through screenings, yet face challenges in ensuring effective follow-up care and resources. Nearly one-third of US public schools require ...
Parents and pediatricians navigate the complexities of neurodiversity, emphasizing the need for open communication and better resources for child development. For many parents, the idea of ...
Specifically, the ACIP voted 5-2 to recommend clesrovimab (Enflonsia; Merck), which was approved by the FDA on June 9, 2025, for infants aged 8 months and younger who are not protected by a maternal ...
The American Academy of Pediatrics will continue to hold its own childhood vaccine schedule, as it has since the 1930s. The new-look Advisory Committee on Immunization Practices (ACIP) will meet on ...
AAP updates clinical guidance to help pediatricians navigate genetic evaluation of children with global developmental delay or intellectual disability. Global developmental delay (GDD) and ...
In this video, part 2 in a 3-part series, panelists discuss clesrovimab's recent approval and gaps in clinician education. As the field of RSV prevention continues to grow, pediatricians face both new ...
Ramilo, a clesrovimab clinical trial investigator, breaks down the recent FDA approval for the newest monoclonal antibody to protect against RSV disease in infants. The June 9, 2025, FDA approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback